Order Article Reprints

Odagiri N, Hai H, Thuy LTT, Dong MP, Suoh M, Kotani K, Hagihara A, Uchida-Kobayashi S, Tamori A, Enomoto M, et al. Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization. Cancers. 2020; 12(8):2045. https://doi.org/10.3390/cancers12082045

Odagiri, Naoshi, Hoang Hai, Le Thi Thanh Thuy, Minh Phuong Dong, Maito Suoh, Kohei Kotani, Atsushi Hagihara, Sawako Uchida-Kobayashi, Akihiro Tamori, Masaru Enomoto, and et al. 2020. "Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization" Cancers 12, no. 8: 2045. https://doi.org/10.3390/cancers12082045

Odagiri, N., Hai, H., Thuy, L. T. T., Dong, M. P., Suoh, M., Kotani, K., Hagihara, A., Uchida-Kobayashi, S., Tamori, A., Enomoto, M., & Kawada, N. (2020). Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization. Cancers, 12(8), 2045. https://doi.org/10.3390/cancers12082045